651 related articles for article (PubMed ID: 26220395)
1. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
2. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
3. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
5. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
6. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
7. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
9. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
Hofmann JW; Seeley WW; Huang EJ
Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of amyotrophic lateral sclerosis.
Liscic RM; Breljak D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
[TBL] [Abstract][Full Text] [Related]
11. Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.
Buratti E
Adv Exp Med Biol; 2021; 1281():243-267. PubMed ID: 33433879
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.
Lagier-Tourenne C; Polymenidou M; Cleveland DW
Hum Mol Genet; 2010 Apr; 19(R1):R46-64. PubMed ID: 20400460
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
14. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
16. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
17. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
[TBL] [Abstract][Full Text] [Related]
18. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
19. Regulation of gene expression by TDP-43 and FUS/TLS in frontotemporal lobar degeneration.
Budini M; Baralle FE; Buratti E
Curr Alzheimer Res; 2011 May; 8(3):237-45. PubMed ID: 21222602
[TBL] [Abstract][Full Text] [Related]
20. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLDÂ spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]